Syenex
Syenex develops cell-specific delivery systems and programmable cell engineering payloads for biotechnology and drug development applications. The company creates optimized enveloped vector surface compositions for high-efficiency, cell type-specific delivery, compatible with a variety of programmable cell engineering payload types. Syenex offers best-in-class delivery solutions for the most impactful therapeutic…
Funding snapshot
About
Syenex develops cell-specific delivery systems and programmable cell engineering payloads for biotechnology and drug development applications. The company creates optimized enveloped vector surface compositions for high-efficiency, cell type-specific delivery, compatible with a variety of programmable cell engineering payload types. Syenex offers best-in-class delivery solutions for the most impactful therapeutic cell types, with technologies designed for scale including CDMO integrations and regulatory support to streamline development from pre-clinical prototyping through clinical validation. The company provides universal access to a continuously improving catalog of cell engineering and delivery technologies, serving drug developers working on cell and gene therapies and other advanced therapeutics. Founded in 2022 and headquartered in Chicago, United States, Syenex has raised approximately $13.7 million in Series B funding from investors including AlleyCorp and KdT Ventures.
Business model
Genomics > Applied Genomics > Synthetic Biology,
Biopharma Outsourcing > CRO > Drug Discovery
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.